Association between reduced low density lipoprotein oxidation and inhibition of monocyte chemoattractant protein-1 production in statin-treated subjects
- 1 February 2005
- journal article
- clinical trial
- Published by Elsevier in Journal of Laboratory and Clinical Medicine
- Vol. 145 (2) , 83-87
Abstract
No abstract availableKeywords
This publication has 20 references indexed in Scilit:
- Statins in atherosclerosis: lipid-lowering agents with antioxidant capabilitiesAtherosclerosis, 2004
- Oxidized Low-Density Lipoprotein Augments and 3-Hydroxy-3-Methylglutaryl Coenzyme A Reductase Inhibitors Limit CD40 and CD40L Expression in Human Vascular CellsCirculation, 2002
- Circulating Oxidized LDL Is Associated With Subclinical Atherosclerosis Development and Inflammatory Cytokines (AIR Study)Arteriosclerosis, Thrombosis, and Vascular Biology, 2002
- Modulation of C-Reactive Protein–Mediated Monocyte Chemoattractant Protein-1 Induction in Human Endothelial Cells by Anti-Atherosclerosis DrugsCirculation, 2001
- Pravastatin Treatment Increases Collagen Content and Decreases Lipid Content, Inflammation, Metalloproteinases, and Cell Death in Human Carotid PlaquesCirculation, 2001
- Elevation of Tumor Necrosis Factor-α and Increased Risk of Recurrent Coronary Events After Myocardial InfarctionCirculation, 2000
- Long-Term Effects of Pravastatin on Plasma Concentration of C-reactive ProteinCirculation, 1999
- Inhibition of proinflammatory cytokine production by pravastatinThe Lancet, 1999
- Atherosclerosis — An Inflammatory DiseaseNew England Journal of Medicine, 1999
- Continuous Monitoring ofin VztroOxidation of Human Low Density LipoproteinFree Radical Research Communications, 1989